| Dr Amy Lynn Gust, MD | |
|
675 Middle Creek Rd, Sevierville, TN 37862-5014 | |
| (865) 453-2039 | |
| Not Available |
| Full Name | Dr Amy Lynn Gust |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 19 Years |
| Location | 675 Middle Creek Rd, Sevierville, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003034851 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 43463 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health Care | Knoxville, TN | Home health agency |
| Leconte Medical Center | Sevierville, TN | Hospital |
| University Of Tn Medical Center | Knoxville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summit Medical Group, Pllc | 2860396330 | 485 |
News Archive
A digital sprint, featuring a series of hackathons, led by Cranfield University and the Natural Environment Research Council has seen multiple projects awarded prizes for innovation and use of digital technology.
Researchers from the Wolfson Faculty of Chemical Engineering at the Technion-Israel Institute of Technology have developed an integrated system for early diagnosis of diseases using wearable monitors.
Zenobia Therapeutics, Inc. the leader in fragment-based lead discovery for CNS diseases, announced today a research collaboration with H. Lundbeck A/S utilizing Zenobia's expertise in protein expression and x-ray crystallography for the Parkinson's disease target, LRRK2. Under the agreement, Zenobia will continue to use its capabilities in fragment-based lead discovery (FBLD) to advance its internal LRRK2 drug discovery program independently of Lundbeck.
Pool pass, sports camp, visiting relatives and getting tonsils removed are all normal activities for children during the summer months.
Advanced Cell Technology, Inc. announced today that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD). Among the most common causes of untreatable blindness in the world are degenerative diseases of the retina.
› Verified 3 days ago
| Entity Name | Summit Medical Group, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659090298 PECOS PAC ID: 2860396330 Enrollment ID: O20031125000793 |
News Archive
A digital sprint, featuring a series of hackathons, led by Cranfield University and the Natural Environment Research Council has seen multiple projects awarded prizes for innovation and use of digital technology.
Researchers from the Wolfson Faculty of Chemical Engineering at the Technion-Israel Institute of Technology have developed an integrated system for early diagnosis of diseases using wearable monitors.
Zenobia Therapeutics, Inc. the leader in fragment-based lead discovery for CNS diseases, announced today a research collaboration with H. Lundbeck A/S utilizing Zenobia's expertise in protein expression and x-ray crystallography for the Parkinson's disease target, LRRK2. Under the agreement, Zenobia will continue to use its capabilities in fragment-based lead discovery (FBLD) to advance its internal LRRK2 drug discovery program independently of Lundbeck.
Pool pass, sports camp, visiting relatives and getting tonsils removed are all normal activities for children during the summer months.
Advanced Cell Technology, Inc. announced today that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD). Among the most common causes of untreatable blindness in the world are degenerative diseases of the retina.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amy Lynn Gust, MD 1225 E Weisgarber Rd, Suite 200, Knoxville, TN 37909-2604 Ph: (865) 584-4747 | Dr Amy Lynn Gust, MD 675 Middle Creek Rd, Sevierville, TN 37862-5014 Ph: (865) 453-2039 |
News Archive
A digital sprint, featuring a series of hackathons, led by Cranfield University and the Natural Environment Research Council has seen multiple projects awarded prizes for innovation and use of digital technology.
Researchers from the Wolfson Faculty of Chemical Engineering at the Technion-Israel Institute of Technology have developed an integrated system for early diagnosis of diseases using wearable monitors.
Zenobia Therapeutics, Inc. the leader in fragment-based lead discovery for CNS diseases, announced today a research collaboration with H. Lundbeck A/S utilizing Zenobia's expertise in protein expression and x-ray crystallography for the Parkinson's disease target, LRRK2. Under the agreement, Zenobia will continue to use its capabilities in fragment-based lead discovery (FBLD) to advance its internal LRRK2 drug discovery program independently of Lundbeck.
Pool pass, sports camp, visiting relatives and getting tonsils removed are all normal activities for children during the summer months.
Advanced Cell Technology, Inc. announced today that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD). Among the most common causes of untreatable blindness in the world are degenerative diseases of the retina.
› Verified 3 days ago
Dr. Eric James Littleton, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 744 Middle Creek Rd, Suite 108, Sevierville, TN 37862 Phone: 865-446-9500 Fax: 865-446-9501 | |
Dr. James John Hollandsworth, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1124 Fox Meadows Blvd Ste 3, Sevierville, TN 37862 Phone: 423-239-5141 Fax: 423-239-4869 | |
Christopher Palmer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 744 Middle Creek Rd Ste 108, Sevierville, TN 37862 Phone: 865-446-9500 Fax: 865-446-9501 | |
Dr. Deborah E Horton, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 227 Cedar St, Sevierville, TN 37862 Phone: 865-453-1032 Fax: 865-453-7271 | |
Richard Allan Dew, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 312 Prince St, Sevierville, TN 37862 Phone: 865-774-7684 | |
Dr. Keri Melancon, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 657 Middle Creek Rd, Sevierville, TN 37862 Phone: 865-428-7586 Fax: 865-428-8671 |